{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:39:59Z","timestamp":1792431599809,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":131,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2023A1515111116"],"award-info":[{"award-number":["2023A1515111116"]}]},{"name":"the Shenzhen Foundation of Science and Technology","award":["JCYJ20230807151308018"],"award-info":[{"award-number":["JCYJ20230807151308018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01164-6","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:44:33Z","timestamp":1781106273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effects of lamotrigine combined with duloxetine in the treatment of bipolar depression"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiaokang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1164_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jad.2025.03.054","volume":"379","author":"H Chen","year":"2025","unstructured":"Chen H, Ding C, Ren J. The burden and trends of depressive disorders in adolescent and young adults aged 15\u201329 in China, 1990\u20132021 and its prediction to 2030: Findings from the Global Burden of Disease Study 2021. J Affect Disord. 2025;379:594\u2013604. https:\/\/doi.org\/10.1016\/j.jad.2025.03.054.","journal-title":"J Affect Disord"},{"key":"1164_CR2","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"1164_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jpsychires.2017.03.025","volume":"92","author":"FP Moreira","year":"2017","unstructured":"Moreira FP, Jansen K, Cardoso TA, Mondin TC, Magalh\u00e3es PVS, Kapczinski F, et al. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study: Metabolic syndrome in current depressive episode. J Psychiatr Res. 2017;92:119\u201323. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.03.025.","journal-title":"J Psychiatr Res"},{"key":"1164_CR4","doi-asserted-by":"publisher","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2). https:\/\/doi.org\/10.1111\/bdi.12609.","DOI":"10.1111\/bdi.12609"},{"issue":"2","key":"1164_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/02698811241309622","volume":"39","author":"RH McAllister-Williams","year":"2025","unstructured":"McAllister-Williams RH, Goudie N, Azim L, Bartle V, Berger M, Butcher C, et al. A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study). J Psychopharmacol. 2025;39(2):106\u201320. https:\/\/doi.org\/10.1177\/02698811241309622.","journal-title":"J Psychopharmacol"},{"key":"1164_CR6","doi-asserted-by":"crossref","unstructured":"Siwek M, Chrobak AA, Sotys Z, Dudek D, Krupa AJ, Rybakowski JKJP. A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression. 2022;56(3):509\u201322.","DOI":"10.12740\/PP\/OnlineFirst\/132962"},{"issue":"2","key":"1164_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1034\/j.1600-0447.2001.00240.x","volume":"104","author":"T Silverstone","year":"2001","unstructured":"Silverstone T. Moclobemide vs. imipramine in bipolar depression: a multicentre double-blindclinical trial. Acta psychiatrica Scandinavica. 2001;104(2):104\u20139. https:\/\/doi.org\/10.1034\/j.1600-0447.2001.00240.x.","journal-title":"Acta psychiatrica Scandinavica"},{"key":"1164_CR8","doi-asserted-by":"publisher","first-page":"204512532110458","DOI":"10.1177\/20451253211045870","volume":"11","author":"FMC Besag","year":"2021","unstructured":"Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol. 2021;11:20451253211045870. https:\/\/doi.org\/10.1177\/20451253211045870.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"9","key":"1164_CR9","doi-asserted-by":"publisher","first-page":"CD013575","DOI":"10.1002\/14651858.CD013575.pub2","volume":"9","author":"Y Hashimoto","year":"2021","unstructured":"Hashimoto Y, Kotake K, Watanabe N, Fujiwara T, Sakamoto S. Lamotrigine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 2021;9(9):CD013575. https:\/\/doi.org\/10.1002\/14651858.CD013575.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1164_CR10","doi-asserted-by":"publisher","unstructured":"Costa B, Vale N. Understanding lamotrigine\u2019s role in the CNS and possible future evolution. Int J Mol Sci. 2023;24(7). https:\/\/doi.org\/10.3390\/ijms24076050.","DOI":"10.3390\/ijms24076050"},{"issue":"4","key":"1164_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s40473-015-0050-5","volume":"2","author":"M Park","year":"2015","unstructured":"Park M, Niciu MJ, Zarate CA. Novel Glutamatergic Treatments for Severe Mood Disorders. Curr Behav Neurosci Rep. 2015;2(4):198\u2013208.","journal-title":"Curr Behav Neurosci Rep"},{"issue":"5","key":"1164_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrd2462","volume":"7","author":"G Sanacora","year":"2008","unstructured":"Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426\u201337. https:\/\/doi.org\/10.1038\/nrd2462.","journal-title":"Nat Rev Drug Discov"},{"key":"1164_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fpsyt.2018.00767","volume":"9","author":"C-T Li","year":"2019","unstructured":"Li C-T, Yang K-C, Lin W-C. Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies. Front Psychiatry. 2019;9:767. https:\/\/doi.org\/10.3389\/fpsyt.2018.00767.","journal-title":"Front Psychiatry"},{"issue":"6","key":"1164_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s43440-024-00656-8","volume":"76","author":"AA Chrobak","year":"2024","unstructured":"Chrobak AA, Siwek M. Drugs with glutamate-based mechanisms of action in psychiatry. Pharmacol Rep. 2024;76(6):1256\u201371. https:\/\/doi.org\/10.1007\/s43440-024-00656-8.","journal-title":"Pharmacol Rep"},{"issue":"21","key":"1164_CR15","doi-asserted-by":"publisher","first-page":"e2401","DOI":"10.1212\/WNL.0000000000007517","volume":"92","author":"T Kim","year":"2019","unstructured":"Kim T, Kulick CG, Kortepeter CM, Brinker A, Waldron P. Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine. Neurology. 2019;92(21):e2401\u20135. https:\/\/doi.org\/10.1212\/WNL.0000000000007517.","journal-title":"Neurology"},{"issue":"6","key":"1164_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/tan.13530","volume":"93","author":"KA Mullan","year":"2019","unstructured":"Mullan KA, Anderson A, Illing PT, Kwan P, Purcell AW, Mifsud NA. HLA-associated antiepileptic drug-induced cutaneous adverse reactions. HLA. 2019;93(6):417\u201335. https:\/\/doi.org\/10.1111\/tan.13530.","journal-title":"HLA"},{"issue":"8","key":"1164_CR17","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.burns.2024.07.006","volume":"50","author":"JZ Glahn","year":"2024","unstructured":"Glahn JZ, Almeida MN, Kochen A, Noel O, Stogner V, Hsia HC, et al. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study. Burns. 2024;50(8):2114\u201323. https:\/\/doi.org\/10.1016\/j.burns.2024.07.006.","journal-title":"Burns"},{"key":"1164_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijpharm.2019.05.077","volume":"566","author":"M Seggio","year":"2019","unstructured":"Seggio M, Contino A, Maccarrone G, Parenti C, Merlo S, Pappalardo G, et al. Preclinical evidence of enhanced analgesic activity of duloxetine complexed with succinyl-\u03b2-cyclodextrin: A comparative study with cyclodextrin complexes. Int J Pharm. 2019;566:391\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.077.","journal-title":"Int J Pharm"},{"issue":"4","key":"1164_CR19","first-page":"321","volume":"161","author":"G Serafini","year":"2010","unstructured":"Serafini G, Pompili M, Del Casale A, Mancini M, Innamorati M, Lester D, et al. Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression. Clin Ter. 2010;161(4):321\u20137.","journal-title":"Clin Ter"},{"key":"1164_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.03.172","author":"L Zhong","year":"2025","unstructured":"Zhong L, Yue Y, Liu X, Chen H, Qian Y, Tang W, et al. The effects of six antidepressants on electrolytes, hepatic and renal function, and glycolipid metabolism in patients with major depressive disorder. J Affect Disord. 2025. https:\/\/doi.org\/10.1016\/j.jad.2025.03.172.","journal-title":"J Affect Disord"},{"issue":"3","key":"1164_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.19852\/j.cnki.jtcm.2025.03.016","volume":"45","author":"Z Yang","year":"2025","unstructured":"Yang Z, Wang L, Xin XU, Jie LI, Shengli HU, Ying W. Clinical effect of Shugan Jieyu San for improving liver function and alleviating depression in patients with triple negative breast cancer. J Tradit Chin Med. 2025;45(3):633\u20138. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2025.03.016.","journal-title":"J Tradit Chin Med"},{"key":"1164_CR22","doi-asserted-by":"publisher","first-page":"107752","DOI":"10.1016\/j.psyneuen.2026.107752","volume":"186","author":"J-M Kim","year":"2026","unstructured":"Kim J-M, Kang H-J, Kim J-W, Jhon M, Lee J-Y, Kim S-W, et al. Personality moderates the predictive value of serum serotonin for antidepressant remission in depressive disorders. Psychoneuroendocrinology. 2026;186:107752. https:\/\/doi.org\/10.1016\/j.psyneuen.2026.107752.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1164_CR23","doi-asserted-by":"publisher","first-page":"112139","DOI":"10.5498\/wjp.v16.i1.112139","volume":"16","author":"M-Y Xu","year":"2026","unstructured":"Xu M-Y, Lu Y, Shi G-M, Yao J, Ding C-Q, Zhou R-J. Clinical efficacy and effects on hypothalamic-pituitary-adrenal axis function of proscar combined with selective serotonin reuptake inhibitor in post-stroke depression. World J Psychiatry. 2026;16(1):112139. https:\/\/doi.org\/10.5498\/wjp.v16.i1.112139.","journal-title":"World J Psychiatry"},{"issue":"4","key":"1164_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/17520363.2026.2641467","volume":"20","author":"S Lee","year":"2026","unstructured":"Lee S, Mun S, Yun Y, Kim D, Lee J, Kang H-G. Identifying predictive proteomic biomarkers of selective serotonin reuptake inhibitor treatment effect in depression. Biomark Med. 2026;20(4):223\u201331. https:\/\/doi.org\/10.1080\/17520363.2026.2641467.","journal-title":"Biomark Med"},{"issue":"Pt A","key":"1164_CR25","doi-asserted-by":"publisher","first-page":"128825","DOI":"10.1016\/j.talanta.2025.128825","volume":"298","author":"X Zhang","year":"2025","unstructured":"Zhang X, Shi K, Rao Z, Chen S, Cao S, Xu Y. An emerging machine learning-optimized MIP-ECL platform for ultrasensitive and selective detection of 5-hydroxytryptamine. Talanta. 2025;298(Pt A):128825. https:\/\/doi.org\/10.1016\/j.talanta.2025.128825.","journal-title":"Talanta"},{"issue":"4","key":"1164_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/08919887211036182","volume":"35","author":"Y Hong","year":"2021","unstructured":"Hong Y, Zeng X, Zhu CW, Neugroschl J, Aloysi A, Sano M, et al. Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older Adults. J Geriatr Psychiatry Neurol. 2021;35(4):586\u201393. https:\/\/doi.org\/10.1177\/08919887211036182.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"1164_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S2215-0366(24)00411-5","volume":"12","author":"C Ermis","year":"2025","unstructured":"Ermis C, Taipale H, Tanskanen A, Vieta E, Correll CU, Mittendorfer-Rutz E, et al. Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort. Lancet Psychiat. 2025;12(3):198\u2013207. https:\/\/doi.org\/10.1016\/S2215-0366(24)00411-5.","journal-title":"Lancet Psychiat"},{"issue":"5","key":"1164_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40261-013-0070-4","volume":"33","author":"V Biton","year":"2013","unstructured":"Biton V, Shneker BF, Naritoku D, Hammer AE, Vuong A, Caldwell PT, et al. Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials. Clin Drug Investig. 2013;33(5):359\u201364. https:\/\/doi.org\/10.1007\/s40261-013-0070-4.","journal-title":"Clin Drug Investig"},{"issue":"3\u20134","key":"1164_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000510327","volume":"106","author":"X Wang","year":"2021","unstructured":"Wang X, Zhao J, Wen T, Liao X, Luo B. Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia. Pharmacology. 2021;106(3\u20134):202\u201310. https:\/\/doi.org\/10.1159\/000510327.","journal-title":"Pharmacology"},{"issue":"1","key":"1164_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/ejhpharm-2021-003053","volume":"31","author":"N Monti Guarnieri","year":"2023","unstructured":"Monti Guarnieri N, Pompilio A, Marini C, Ortenzi GB, Andresciani E, Garzone AMF, et al. A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy. Eur J Hosp Pharm. 2023;31(1):46\u20139. https:\/\/doi.org\/10.1136\/ejhpharm-2021-003053.","journal-title":"Eur J Hosp Pharm"},{"key":"1164_CR31","doi-asserted-by":"publisher","unstructured":"Tu L, Xiao J, Hong Q, Ouyang A, Tu Y, Wang S. Assessment of adverse events of the novel antiepileptic drug lamotrigine: a real-world pharmacovigilance study based on FAERS. Expert Opin Drug Saf. 2025. https:\/\/doi.org\/10.1080\/14740338.2025.2465867.","DOI":"10.1080\/14740338.2025.2465867"},{"issue":"1","key":"1164_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12883-021-02363-w","volume":"21","author":"N Shafeng","year":"2021","unstructured":"Shafeng N, Han D-F, Ma Y-F, Abudusalamu R, Ayitimuhan B. Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China. BMC Neurol. 2021;21(1):340. https:\/\/doi.org\/10.1186\/s12883-021-02363-w.","journal-title":"BMC Neurol"},{"issue":"5","key":"1164_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/epi.17563","volume":"64","author":"S Diederich","year":"2023","unstructured":"Diederich S, Hemmeter U, Paulmann M, Mockenhaupt M. Effects of dosage in new users of lamotrigine inducing epidermal necrolysis: Results of the German Registry of Severe Skin Reactions. Epilepsia. 2023;64(5):1259\u201365. https:\/\/doi.org\/10.1111\/epi.17563.","journal-title":"Epilepsia"},{"issue":"13","key":"1164_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.2022.3880","volume":"327","author":"AM Kanner","year":"2022","unstructured":"Kanner AM, Bicchi MM. Antiseizure Medications for Adults With Epilepsy: A Review. JAMA. 2022;327(13):1269\u201381. https:\/\/doi.org\/10.1001\/jama.2022.3880.","journal-title":"JAMA"},{"key":"1164_CR35","doi-asserted-by":"publisher","first-page":"111041","DOI":"10.1016\/j.cbi.2024.111041","volume":"397","author":"L Chen","year":"2024","unstructured":"Chen L, Chen X, Liu J, Yang J, Xu R-A. Effects of two commonly used antidepressants amitriptyline and fluoxetine on the pharmacokinetics of abrocitinib in rats. Chem Biol Interact. 2024;397:111041. https:\/\/doi.org\/10.1016\/j.cbi.2024.111041.","journal-title":"Chem Biol Interact"},{"key":"1164_CR36","doi-asserted-by":"publisher","unstructured":"Maciaszek J, Paw\u0142owski T, Hadry\u015b T, Machowska M, Wiela-Hoje\u0144ska A, Misiak B. The impact of the CYP2D6 and CYP1A2 gene polymorphisms on response to duloxetine in patients with major depression. Int J Mol Sci. 2023;24(17). https:\/\/doi.org\/10.3390\/ijms241713459.","DOI":"10.3390\/ijms241713459"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01164-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01164-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01164-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:02:12Z","timestamp":1792429332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01164-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01164-6","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research involving human participants, human material have been performed in accordance with the Declaration of Helsinki and have been approved by the Ethics Committee of Shenzhen Longhua District Central Hospital, the Affiliated Longhua Hospital of Shenzhen University (ID number: 2023-005-01). A signed informed consent form was obtained from all patients included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"143"}}